Sands Capital Management’s Repligen RGEN Stock Holding History

Sands Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,251,088	Closed	-$156M	–	70
2025 Q2	$156M	Sell	1,251,088 -43,108	-3%	-$5.49M	0.45%	41
2025 Q1	$165M	Sell	1,294,196 -70,062	-5%	-$10.8M	0.56%	38
2024 Q4	$196M	Sell	1,364,258 -54,805	-4%	-$7.86M	0.58%	37
2024 Q3	$211M	Sell	1,419,063 -2,469	-0.2%	-$354K	0.64%	37
2024 Q2	$179M	Sell	1,421,532 -11,205	-0.8%	-$1.76M	0.53%	43
2024 Q1	$264M	Sell	1,432,737 -62,600	-4%	-$11.9M	0.74%	35
2023 Q4	$269M	Sell	1,495,337 -75,026	-5%	-$11.7M	0.82%	34
2023 Q3	$250M	Sell	1,570,363 -23,816	-1%	-$3.89M	0.85%	35
2023 Q2	$226M	Sell	1,594,179 -20,672	-1%	-$3.31M	0.7%	40
2023 Q1	$272M	Sell	1,614,851 -166,588	-9%	-$29.7M	0.9%	35
2022 Q4	$302M	Buy	1,781,439 +142,480	+9%	+$25.8M	1.14%	28
2022 Q3	$307M	Buy	+1,638,959	New	+$346M	1.15%	29

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Sands Capital Management's RGEN Position: Q3 2025 in Review

Sands Capital Management sold out of Repligen (RGEN) in Q3 2025, closing a stake of 1,251,088 shares — an estimated $156M sold.

Sands Capital Management first reported a position in RGEN in Q3 2022 and held it in 12 quarters. The position peaked at $307M in Q3 2022. 453 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

Sands Capital Management reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
Sands Capital Management sold 1,251,088 Repligen shares in Q3 2025, an estimated $156M.
Sands Capital Management first reported a position in Repligen in Q3 2022 and held it in 12 quarters.
Sands Capital Management's Repligen position peaked at $307M in Q3 2022.
453 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Sands Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.